SUGAR LAND--February 26, 2013--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Massachusetts has long been a darling of the Pharmaceutical-Biotech Industry. Perceived as a huge brain trust of intellectual capital, the state continues to attract billions of dollars in capital investment from both the private and public sectors. A recent survey of reported capital projects in Industrial Info's Pharmaceutical Tracker - Online Database revealed a total of 26 projects currently under construction, with a total investment value of $3.4 billion.
Other companies featured: Pfizer (NYSE:PFE), PerkinElmer (NYSE:PKI)
This Premium Article can be purchased individually or as part of a Premium News subscription